Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK's new drug application (NDA) for Blenrep ...

Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...

King of Prussia, Pennsylvania Monday, September 16, 2024, 17:00 Hrs [IST] ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

Osaka Metropolitan University researchers analyzed the incidence in Japan of COVID-19-associated pulmonary aspergillosis ...

In the past 60 days, the Zacks Consensus Estimate for Arcturus’ 2024 loss per share has narrowed from $4.39 to $2.60. Also, the Zacks Consensus Estimate for 2025 has moved from a loss of 45 cents to ...

Investigating Japanese longevity reveals the impact of lifestyle medicine and government strategies on health, offering ...

CSL and self-amplifying mRNA (sa-mRNA) pioneer Arcturus Therapeutics today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) granted approval and authorization for their updated ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

Rayne Beau, a lost cat, managed to travel 800 miles back home after vanishing during a camping trip in Yellowstone National Park. Found exhausted in Roseville, California, he was reunited with his ...

Aug. 21, 2024 — Lithium iron phosphate is one of the most important materials for batteries in electric cars, stationary energy storage systems and tools. It has a long service life, is ...

Sep. 19, 2024 — Rising temperatures are thought to reduce the number of ice crystals in clouds, leading to the formation of liquid-dominated clouds. However, a new study has found that Arctic ...